CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 5,927	$ 4,503
Restricted cash	0	733
Interest, accounts receivable, and other receivables, net	5,788	4,729
Assets held for sale, net (Note 7)	6,398	0
Other current assets	2,141	1,904
Total current assets	20,254	11,869
Finance receivables, net of allowance for credit losses of $11,249 and $13,901 as of December 31, 2024 and December 31, 2023, respectively	277,760	274,504
Collateral on foreign currency forward contract	2,750	2,750
Marketable investments	580	48
Deferred tax assets, net	23,484	28,290
Warrant assets	4,366	1,759
Intangible assets, net	0	6,487
Property and equipment, net	48	5,438
Other non-current assets	2,993	3,109
Total assets	332,235	334,254
Current liabilities:
Accounts payable and accrued liabilities	2,810	3,935
Liabilities held for sale (Note 7)	1,255	0
Deferred income	1,500	9
Total current liabilities	5,565	3,944
Contingent consideration payable	0	4,900
Unsecured senior notes, net	31,412	30,781
Revolving credit facility	6,233	12,350
Other non-current liabilities	335	1,964
Total liabilities	43,545	53,939
Commitments and contingencies (Note 9)
Stockholders' equity:
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	0	0
Common stock, $0.001 par value; 250,000,000 shares authorized; 12,213,599 and 12,497,770 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively	12	12
Additional paid-in capital	4,419,991	4,425,104
Accumulated deficit	(4,131,313)	(4,144,801)
Total stockholders' equity	288,690	280,315
Total liabilities and stockholders' equity	$ 332,235	$ 334,254